Abpro Holdings, Inc. financial data

Symbol
ABP, ACAB, ABPWW, ACABU, ACABW on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
6 St Johns Lane, Floor 5, New York, NY
State of incorporation
DE
Fiscal year end
December 31
Former names
Atlantic Coastal Acquisition Corp. II (to 11/12/2024)
Latest financial report
10-Q - Q3 2024 - Nov 26, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 54.6 % +93.9%
Debt-to-equity -148 % -31.4%
Return On Equity 10.2 %
Return On Assets -11.4 % -566%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 51.5M shares
Entity Public Float 0 USD

Income Statement

Label TTM Value / Value Unit Change %
Operating Income (Loss) -2.32M USD -24.6%
Nonoperating Income (Expense) 731K USD -90.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -1.59M USD -127%
Income Tax Expense (Benefit) 142K USD -91.3%
Net Income (Loss) Attributable to Parent -1.73M USD -140%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 13.6K USD -98.6%
Assets, Current 1.56M USD +48.1%
Assets 7.86M USD -79.1%
Accrued Liabilities, Current 469K USD -62.3%
Liabilities, Current 9.04M USD +64.1%
Liabilities 19.5M USD +22.1%
Retained Earnings (Accumulated Deficit) -17.8M USD -18.3%
Stockholders' Equity Attributable to Parent -17.8M USD -18.3%
Liabilities and Equity 7.86M USD -79.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -264K USD -171%
Net Cash Provided by (Used in) Financing Activities -29.7M USD
Net Cash Provided by (Used in) Investing Activities 29.7M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -254K USD -161%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 13.6K USD -98.6%
Deferred Tax Assets, Valuation Allowance 687K USD +76.8%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Cash and Cash Equivalents, Period Increase (Decrease) 331K USD
Deferred Tax Assets, Gross 687K USD +76.8%
Deferred Tax Assets, Operating Loss Carryforwards 0 USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1M shares 0%
Unrecognized Tax Benefits 0 USD
Additional Paid in Capital 0 USD
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%